Abiopharma

🔍 Gaba Greg (Executive)

Company: SunOpta Inc. (STKL)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Sold 127,908 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: D | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
• Sold 64,386 shares of Restricted Stock Unit (RSU) (Derivative)
  Date: 2026-05-01 | Code: D | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F3, F3, F3
• Sold 138,580 shares of Performance Stock Units (Derivative)
  Date: 2026-05-01 | Code: D | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F4, F5, F5, F5
• Sold 2,891 shares of Stock Option (right to buy Common Stock) at $4.73 per share (Derivative)
  Date: 2026-05-01 | Code: D | Expires: 2030-07-10 | Exercise: 2021-07-10 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F6
• Sold 7,204 shares of Stock Option (right to buy Common Stock) at $5.91 per share (Derivative)
  Date: 2026-05-01 | Code: D | Expires: 2032-05-05 | Exercise: 2023-05-05 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F6
• Sold 26,094 shares of Stock Option (right to buy Common Stock) at $6.35 per share (Derivative)
  Date: 2026-05-01 | Code: D | Expires: 2033-07-10 | Exercise: 2024-07-10 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F6
• Sold 61,059 shares of Stock Option (right to buy Common Stock) at $3.92 per share (Derivative)
  Date: 2026-05-01 | Code: D | Expires: 2035-04-11 | Exercise: 2026-04-11 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F6

Footnotes:

• F1: Pursuant to the Arrangement Agreement (the "Arrangement Agreement"), dated as of February 6, 2026, by and among SunOpta Inc. ("SunOpta"), Pegasus BidCo B.V. ("Parent") and 2786694 Alberta Ltd. ("Purchaser"), Purchaser acquired all of SunOpta's issued and outstanding common shares in the capital of SunOpta (the "Common Shares") by way of a court-approved statutory plan of arrangement under Section 192 of the Canada Business Corporations Act (the "Arrangement"). At the effective time of the Arrangement (the "Effective Time"), each of SunOpta's issued and outstanding Common Shares were transferred to Purchaser for consideration of $6.50 per share in cash, less applicable withholdings (the "Consideration").
• F2: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock.
• F3: At the Effective Time, each restricted stock unit ("RSU") held by the reporting person was surrendered in exchange for, subject to any withholding, a cash payment equal to the Consideration in respect of each Common Share underlying such RSU.
• F4: Each Performance Based Restricted Stock Unit represents a contingent right to receive one share of STKL common stock.
• F5: Represents the number of performance share units ("PSUs") held by the reporting person that was determined pursuant to the Arrangement Agreement to be entitled to Consideration in the Arrangement. At the Effective Time, each of these PSUs was surrendered in exchange for, subject to any withholding, a cash payment equal to the Consideration in respect of each Common Share underlying such PSU. Each PSU that was not entitled to Consideration in the Arrangement was cancelled without any consideration.
• F6: At the Effective Time, each stock option held by the reporting person was surrendered in exchange for, subject to any withholding, a cash payment equal to the amount (if any) by which the Consideration in respect of a Common Share underlying such stock option exceeds the exercise price of such stock option, multiplied by the number of Common Shares subject to such stock option. Each stock option with a per share exercise price greater than or equal to the Consideration was cancelled without any consideration.